PSY, the famous South Korean singer, is under scrutiny over his medication handling. A doctor recently challenged PSY’s claim that his manager’s collection of his drugs was only a proxy pickup. Instead, the doctor stated this practice amounts to a proxy prescription. This has stirred legal concerns and public discussion.
On August 28, 2025, Seoul police confirmed an investigation into PSY and a university hospital doctor. Authorities suspect they violated the Medical Service Act. PSY allegedly received prescriptions for Xanax and Stilnox without seeing a doctor in person. Moreover, his manager picked up these drugs on his behalf. Both medications are classified as psychotropic substances, requiring face-to-face consultations under South Korean law.
PSY’s agency admitted that his manager collecting his sleep medication by proxy was a serious mistake.However, they denied that a proxy prescription had occurred. The agency explained that PSY had a chronic sleep disorder diagnosis and followed prescribed dosage instructions correctly.
Despite the agency’s statement, a medical professional publicly refuted this explanation. The doctor argued that allowing a third party to receive prescriptions counts as a proxy prescription. They also stressed that telemedicine cannot legally be used to prescribe psychotropic drugs. Therefore, the manager’s proxy pickup suggests a violation of the law over an extended period.
This controversy emphasizes the strict rules governing the prescription and collection of psychotropic medications in South Korea. Violating the Medical Service Act, especially involving controlled substances, carries harsh penalties. The ongoing investigation could result in significant legal consequences for PSY and the involved doctor.
The case also highlights the importance of following legal and ethical standards in medical care. Specifically, it shows how authorities must closely regulate prescriptions for controlled substances. The investigation’s outcome might influence how similar cases will be managed in the future.
In summary, PSY’s proxy prescription situation remains under investigation. The legal implications and public reaction show the seriousness of adhering to medical laws in South Korea.
